At least a dozen brands of asparaginase, a key childhood chemotherapy drug, have failed quality tests. January 26, 2024Check out STAT+Sponsored By Evangeline Gallagher/TBIJ 'The response defies belief': Year of inaction leaves children at risk from bad cancer drugs A dozen brands of asparaginase, a childhood chemotherapy drug, failed quality tests, but the WHO has yet to issue a global product alert. By Rosa Furneaux and Laura Margottini — TBIJ HPV vaccine study finds zero cases of cervical cancer among women vaccinated before age 14 No cervical cancer cases were detected in Scotland in women born between 1988-1996 and fully vaccinated against HPV between ages 12 to 13, study says. By Annalisa Merelli STAT+ | Early detection of pancreatic cancer could get a boost from AI that identifies people at higher risk AI models could enlarge the group of pancreatic cancer patients who can benefit from screening from 10 percent to 35 percent. By Felice J. Freyer — Boston Globe More around STATCheck out more exclusive coverage with a STAT+ subscriptionRead premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.Enjoying Cancer Briefing? Tell us about your experienceContinue reading the latest health & science news with the STAT appDownload on the App Store or get it on Google Play STAT, 1 Exchange Place, Boston, MA©2024, All Rights Reserved.I no longer wish to receive STAT emailsUpdate Newsletter Preferences • Contact Us • Advertise with Us • View in Browser
No comments